Skip to main content
SpringerLink
Log in

Study of genetic, metabolic and inflammatory risk factors in patients of acute ischemic stroke

  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Stroke is the third leading cause of death and foremost cause of disability. Based on studies in CAD patients, a focus has been shifted on genetic and inflammatory markers as risk factors for stroke besides deranged lipid profile. The present study was aimed to ascertain the role of Lipoprotein (a), C-Reactive protein (CRP) levels and lipids in patients of ischemic stroke. The study was done in 82 subjects including 40 Computerized Tomography (CT) proven patients of ischemic stroke and 42 age and sex matched controls. Complete biochemical parameters including lipid profile were carried out on autoanalyzer using standard kits and reagents. Lipoprotein (a) [Lp(a)] was determined by immunoturbidimetric assay. Atherogenic indices (Total cholesterol/ HDL, LDL/HDL and Lipid Tetrad Index) were calculated using these lipid parameters. The CRP levels were measured semi-quantitatively by latex agglutination test method. Out of 40 stroke patients, 38 had abnormalities in lipid profile (As per ATP III guidelines). A significant difference was seen in serum cholesterol, LDL cholesterol and atherogenic indices between the patients and controls. The difference in CRP levels in cases and control subjects was highly significant (4.78±0.72 mg/dl vs 0.76 ±0.70, p<0.001). 96.5% of patients with raised CRP had abnormal lipid levels also. CRP levels in stroke patients showed significant correlation with total cholesterol and LDL (p<0.001), Lp (a) (p=0.002) and atherogenic indices (p<0.05). Raised CRP levels in stroke patients were significantly associated with large territory infarcts, severe disability and poor functional outcome (p<0.05).Genetic [Lp(a)], metabolic (deranged Lipid profile) and inflammatory factors (CRP) together are instrumental in causing cerebrovascular arteriosclerosis leading to ischaemic stroke and can be used as important markers to identify patients at risk of severe stroke and to institute aggressive preventive strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sethi PK. Stroke-Incidence in India and management of ischemic stroke. Neurosciences 2002; 6(3): 139–143.

    Google Scholar 

  2. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics — 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115: e69–e171.

    Article  PubMed  Google Scholar 

  3. Mackay J, Mensah GA. The Atlas of Heart Disease and Stroke. Published by WHO in collaboration with USA’s Centers for Disease Control and Prevention (CDC). September 2004.

  4. Dalal P, Bhattacharjee M, Vairale J, Bhat P. UN millennium development goals: Can we halt the stroke epidemic in India?. Ann Indian Acad Neurol 2007; 10:130–36.

    Google Scholar 

  5. Enas EA. Why is there an epidemic of Malignant CAD in young Indians? Asian J of Clin Cardiol 1998: 1: 43–59.

    Google Scholar 

  6. Enas EA. Coronary artery epidemic in Indians: A cause for alarm and call for action. JIMA 2000; 98: 694–702.

    PubMed  CAS  Google Scholar 

  7. Tanne D, Benderly M, Goldbourt U, Haim M, Tenenbaum A, Fisman EZ, Matas Z, Adler Y, Zimmlichman R, Behar S. CReactive Protein as a Predictor of Incident Ischemic Stroke Among Patients With Preexisting Cardiovascular Disease. Stroke 2006; 37: 1720–1724.

    Article  PubMed  CAS  Google Scholar 

  8. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, D’Agostino RB, Franzblau C, Wilson PW. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham Study. Stroke 2001; 32: 2575–2579.

    Article  PubMed  CAS  Google Scholar 

  9. Curb JD, Abbott RD, Rodriguez BL, Sakkinen P, Popper JS, Yano K, Tracy RP. C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation 2003; 107: 2016–2020.

    Article  PubMed  Google Scholar 

  10. Wakugawa Y, Kiyohara Y, Tanizaki Y, Kubo M, Ninomiya T, Hata J, Doi Y, Okubo K, Oishi Y, Shikata K, Yonemoto K, Maebuchi D, Ibayashi S, Iida M. C-reactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population: the Hisayama Study. Stroke 2005; 37: 27–32.

    Article  PubMed  Google Scholar 

  11. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, Rubin SM, Ding J, Simonsick EM, Harris TB, Pahor M. Inflammatory markers and onset of cardiovascular events: results from the Health ABC Study. Circulation, 2003; 108: 2317–2322.

    Article  PubMed  CAS  Google Scholar 

  12. Kuo HK, Yen CJ, Chang CH, Kuo CK, Chen JH, Sorond F. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol 2005; 4: 371–380.

    Article  PubMed  CAS  Google Scholar 

  13. Danesh J, Collins R, Peto R. Lipoprotein (a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 2000; 102:1082–1085.

    PubMed  CAS  Google Scholar 

  14. Foody JM, Milberg JA, Robinson K, Pearce GL, Jacobsen DW, Sprecher DL. Homocysteine and Lipoprotein (a) Interact to Increase CAD Risk in Young Men and Women. Arteriosclerosis, Thrombosis, and Vascular Biology 2000; 20(2):493–499.

    PubMed  CAS  Google Scholar 

  15. Scanu AM. Lipoprotein (a): A genetically determined cardiovascular pathogen in search of a function. J Lab Clin Med 1990; 116:142–146.

    PubMed  CAS  Google Scholar 

  16. Enas EA. Lipoprotein (a) is an important genetic risk factor for coronary artery disease in Asian Indians. Am J Cardiol 2001; 88: 201–202.

    Article  PubMed  CAS  Google Scholar 

  17. Gambhir JK, Kaur H, Gambhir DS, Prabhu KM. Lipoprotein (a) as an independent risk factor for coronary artery disease in patients below 40 years of age. Ind Heart J 2000; 52: 407–410.

    Google Scholar 

  18. Danie J Rader, Michael H. Davidson, Richard J. Caplan, John S. Pears; Lipid and Apolipoprotein Ratios: Association with Coronary Artery disease and Effects of Rosuvastatin Compared with Atorvastatin, Pravastatin, and Simvastatin.; American Journal of Cardiology; March 6, 2003; 91(5A); 20C–24C.

    Article  PubMed  CAS  Google Scholar 

  19. Enas EA, Yusuf S, Mehta J. Meeting of the IWG on Coronary Artery Disease in South Asians. Indian Heart Journal 1996; 48:727–732.

    PubMed  CAS  Google Scholar 

  20. Ridker PM, Rifai N, Rolec, Buring J E, Cook N R. Comparison of C-reactive protein and low density lipoprotein cholesterol levels in prediction of first cardiovascular event. N Engl J Med 2002 Nov 14; 347(20): 1557–1565.

    Article  PubMed  CAS  Google Scholar 

  21. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998 May 26: 97(20): 2007–2011.

    PubMed  CAS  Google Scholar 

  22. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.

    Google Scholar 

  23. Winbeck K, Poppert H, Etgen T, Conrad B, Sander D. Prognostic relevance of early serial C Reactive protein measurements after first ischemic stroke. Stroke 2002; 33: 2459–2464.

    Article  PubMed  CAS  Google Scholar 

  24. Oliviero U, Orefice G, Coppola G, Scherillo G, Ascione S, Casaburi C, Barbieri F, Sacca L. Carotid atherosclerosis and ischemic stroke in young patients. Int Angiol 2002; 21(2): 117–122.

    PubMed  CAS  Google Scholar 

  25. Kurtzke JF. Epidemiology of Cerebrovascular disease. In Cerebrovascular Survey Report for Joint Council Sub Committee on Cerebrovascular disease. NINDS and Stroke NHLI (Revised): Whiting Press: 1980 135–176.

  26. Kurth T, Everett BM, Buring JE, Kase CS, Ridker PM, Gaziano JM. Lipid levels and the risk of ischemic stroke in women. Neurology 2007; 68(8): 556–562.

    Article  PubMed  CAS  Google Scholar 

  27. Immanuel S, Giantini A, Dharma RS, Samino. The role of lipid profile as a risk factor indicator for ischemic stroke at Cipto Mangunkusumo Hospital, Jakarta. Acta Med Indones 2006; 38(1): 11–16.

    PubMed  Google Scholar 

  28. Cao JJ, Thach C, Manolio TA, Psaty BM, Kuller LH, Chaves PHM, Polak JF, Sutton-Tyrrell K, Herrington DM, Price TR, Cushman M. C-reactive protein, carotid intima media thickness and incidence of Stroke in elderly: the Cardiovascular Health Study. Circulation 2003; 108: 166–170.

    Article  PubMed  CAS  Google Scholar 

  29. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, D’Agostino RB, Franzblau C, Wilson PW. Plasma concentration of C-reactive protein and risk of ischaemic stroke and transient ischemic attack: the Framingham study. Stroke 2001; 32(11): 2575–2579.

    Article  PubMed  CAS  Google Scholar 

  30. Vikram NK, Misra A, Dwivedi M, Sharma R, Pandey RM, Luthra K, Chatterjee A, Dhingra V, Jailkhani BL, Talwar KK, Guleria R. Correlations of C-reactive protein levels with anthropometric profile, percentage of body fat and lipids in healthy adolescents and young adults in urban North India. Atherosclerosis 2003;168(2): 305–313.

    Article  PubMed  CAS  Google Scholar 

  31. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135–1143.

    Article  PubMed  CAS  Google Scholar 

  32. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR. C-reactive protein and outcome after ischaemic stroke. Stroke 1999 May; 30(5); 981-985.

  33. Guo Y, Jiang X, Chen S, Zhao ZW, Gu KY. C-Reactive Protein as an important prognostic marker for ischaemic Stroke. Chinese J Prev Med 2003; 37: 102–104.

    Article  CAS  Google Scholar 

  34. Panicker JN, Thomas, Pavithran K, Nair D, Sarma PS. Morbidity Predictors in Ischaemic Stroke. Neurology India 2003; 51: 49–51.

    PubMed  CAS  Google Scholar 

  35. Di Napoli M, Papa F, Bacola V. Prognostic influence of increased C Reactive Protein and fibrinogen levels in ischaemic stroke. Stroke 2001; 32: 133–138.

    PubMed  Google Scholar 

  36. Angerio AD, Bialko MF, White BM. C-reactive protein, stroke, statins. Cardiac Emergencies. Critical Care Nursing Quarterly 2007; 30(2): 161–165.

    Google Scholar 

  37. Mendall MA, Patel P, Ballam L, Strachen D, Northfield T C. C Reactive-protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996; 312: 1061–1065.

    PubMed  CAS  Google Scholar 

  38. Liu L, Zhao SP, Cheng YC, Li YL. Xuezhikang decreases serum lipoprotein (a) and C-reactive protein concentrations in patients with coronary artery disease. Clin Chem 2003; 49: 1347–1352.

    Article  PubMed  Google Scholar 

  39. Di napoli M, Papa F. Angiotensin converting enzyme inhibitor use is associated with reduced plasma conc. of C Reacctive protein in patients with first ever ischaemic stroke. Stroke 2003; 12: 2922–2929.

    Article  Google Scholar 

  40. Di napoli M, Papa F. Villa Pini Stroke Data Bank Investigators. Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first ever stroke patients. Stroke 2002; 33: 1763–1771.

    Article  PubMed  Google Scholar 

  41. Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur Heart J 2006; 27: 136–143.

    Article  PubMed  Google Scholar 

  42. Boos CJ, Lip GY, Jilma B. Endotoxemia, inflammation and atrial fibrillation. The Am J Cardiol 2007; 100: 986–988.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Lady Hardinge Medical College & Smt Sucheta Kriplani Hospital, New Delhi, 110001, India

    Rajinder K. Dhamija, Sarika Arora, P. Gaba, M. Jais, A. Kaintura, M. Kumar & J. Bhattacharjee

  2. Department of Biochemistry, Lady Hardinge Medical College & Smt Sucheta Kriplani Hospital, New Delhi, 110001, India

    Sarika Arora & J. Bhattacharjee

  3. Department of Microbiology, Lady Hardinge Medical College & Smt Sucheta Kriplani Hospital, New Delhi, 110001, India

    M. Jais

Authors
  1. Rajinder K. Dhamija
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sarika Arora
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Gaba
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Jais
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Kaintura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. Bhattacharjee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sarika Arora.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dhamija, R.K., Arora, S., Gaba, P. et al. Study of genetic, metabolic and inflammatory risk factors in patients of acute ischemic stroke. Indian J Clin Biochem 23, 136–143 (2008). https://doi.org/10.1007/s12291-008-0031-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-008-0031-5

Key Words

Search

Navigation